Category - Executive Moves

Executive Moves

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining Fibrocor, Mr. Walewicz...

January 7, 2021

Executive Moves

iBio names renowned drug discovery and development expert Martin Brenner as CSO

iBio (NYSE American:IBIO) appointed Martin Brenner, Doctor of Veterinary Medicine, Ph.D., as chief scientific officer, effective Jan. 18, 2021. Dr. Brenner has a strong history of success heading drug discovery and...

December 28, 2020

Executive Moves

PDS Biotechnology names Seth Van Voorhees as CFO

PDS Biotechnology (NASDAQ:PDSB) appointed Seth Van Voorhees, Ph.D., as its new CFO, effective Jan. 1, 2021. He replaces Michael King, who served as interim CFO. Dr. Van Voorhees most recently was CFO of Research...

December 9, 2020

Executive Moves

Benjamin Bowen joins Roth’s healthcare investment banking team

Benjamin Bowen, Ph.D., has joined Roth Capital Partners as managing director, healthcare investment banking. Prior to joining Roth, Dr. Bowen most recently was managing director in the investment banking group at...

December 4, 2020

Executive Moves

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed financial executive, Murielle Lortie, as a director, effective immediately. Ms. Lortie is the CFO of Liminal Biosciences, a Nasdaq-listed, clinical-stage...

November 30, 2020

Executive Moves

ObsEva names Brian O’Callaghan as CEO

ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1. He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a director of the company. Mr...

November 9, 2020

Executive Moves

Marizyme names Neil Campbell as president and CEO

Marizyme (NASDAQ:MRZM) appointed Neil Campbell, Ph.D., as CEO, replacing executive chairman James Sapirstein, who has been the company’s interim CEO since September 2020. Dr. Campbell currently serves as chairman of...

November 6, 2020

Executive Moves

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

LogicBio Therapeutics (NASDAQ:LOGC) appointed Mariana Nacht, Ph.D., as CSO, effective Nov. 30; and promoted Kyle Chiang, Ph.D., to the role of COO, effective Nov. 2. The company is expanding its leadership team to...

November 3, 2020

Executive Moves

Aethlon Medical names Charles Fisher as CEO

Aethlon Medical (NASDAQ:AEMD) appointed Charles Fisher, M.D., as CEO, effective Oct. 30. Dr. Fisher joined Aethlon as a member of its board and served as its chairman since November 2017. He succeeds Dr. Timothy Rodell...

November 3, 2020

Executive Moves

iBio appoints global biotech operations expert, Randy Maddux, as COO

iBio (NYSE AMERICAN:IBIO) appointed biotech industry veteran, Randy Maddux, as COO, effective Dec. 1. Mr. Maddux has more than 20 years of global biologics drug development and manufacturing, business development and...

November 3, 2020

Category - Executive Moves

Fibrocor Therapeutics names biotech veteran Joseph Walewicz as CFO

iBio names renowned drug discovery and development expert Martin Brenner as CSO

PDS Biotechnology names Seth Van Voorhees as CFO

Benjamin Bowen joins Roth’s healthcare investment banking team

Profound Medical appoints accomplished financial executive, Murielle Lortie, to board

ObsEva names Brian O’Callaghan as CEO

Marizyme names Neil Campbell as president and CEO

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

Aethlon Medical names Charles Fisher as CEO

iBio appoints global biotech operations expert, Randy Maddux, as COO

General

More